Literature DB >> 12928466

Prevalence of conventional risk factors in patients with coronary heart disease.

Umesh N Khot1, Monica B Khot, Christopher T Bajzer, Shelly K Sapp, E Magnus Ohman, Sorin J Brener, Stephen G Ellis, A Michael Lincoff, Eric J Topol.   

Abstract

CONTEXT: It is commonly suggested that more than 50% of patients with coronary heart disease (CHD) lack any of the conventional risk factors (cigarette smoking, diabetes, hyperlipidemia, and hypertension). This claim implies that other factors play a significant role in CHD and has led to considerable interest in nontraditional risk factors and genetic causes of CHD.
OBJECTIVE: To determine the prevalence of the 4 conventional risk factors among patients with CHD. DESIGN, SETTING, AND PATIENTS: In 2002-2003, we analyzed data for 122458 patients enrolled in 14 international randomized clinical trials of CHD conducted during the prior decade. Patients included 76716 with ST-elevation myocardial infarction, 35527 with unstable angina/non-ST-elevation myocardial infarction, and 10215 undergoing percutaneous coronary intervention. MAIN OUTCOME MEASURES: Prevalence of each conventional risk factor and number of conventional risk factors present among patients with CHD, compared between men and women and by age at trial entry.
RESULTS: Among patients with CHD, at least 1 of the 4 conventional risk factors was present in 84.6% of women and 80.6% of men. In younger patients (men < or =55 years and women < or =65 years) and most patients presenting either with unstable angina or for percutaneous coronary intervention, only 10% to 15% of patients lacked any of the 4 conventional risk factors. This pattern was largely independent of sex, geographic region, trial entry criteria, or prior CHD. Premature CHD was related to cigarette smoking in men and cigarette smoking and diabetes in women. Smoking decreased the age at the time of CHD event (at trial entry) by nearly 1 decade in all risk factor combinations.
CONCLUSIONS: In direct contrast with conventional thinking, 80% to 90% of patients with CHD have conventional risk factors. Although research on nontraditional risk factors and genetic causes of heart disease is important, clinical medicine, public health policies, and research efforts should place significant emphasis on the 4 conventional risk factors and the lifestyle behaviors causing them to reduce the epidemic of CHD.

Entities:  

Mesh:

Year:  2003        PMID: 12928466     DOI: 10.1001/jama.290.7.898

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  346 in total

Review 1.  Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment.

Authors:  Yasushi Matsuzawa; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-12       Impact factor: 1.439

2.  Effect of Alzheimer caregiving on circulating levels of C-reactive protein and other biomarkers relevant to cardiovascular disease risk: a longitudinal study.

Authors:  Roland von Känel; Paul J Mills; Brent T Mausbach; Joel E Dimsdale; Thomas L Patterson; Michael G Ziegler; Sonia Ancoli-Israel; Matthew Allison; Elizabeth A Chattillion; Igor Grant
Journal:  Gerontology       Date:  2011-11-29       Impact factor: 5.140

Review 3.  Phenotyping patient-derived cells for translational studies in cardiovascular disease.

Authors:  Stanley Y Shaw; Ari D Brettman
Journal:  Circulation       Date:  2011-11-29       Impact factor: 29.690

4.  4th Annual Symposium on Self Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 12-14, 2011, Budapest, Hungary.

Authors:  Boris N Mankovsky
Journal:  Diabetes Technol Ther       Date:  2011-10-04       Impact factor: 6.118

Review 5.  New advances in noninvasive imaging of the carotid artery: CIMT, contrast-enhanced ultrasound, and vasa vasorum.

Authors:  Blai Coll; Vijay Nambi; Steven B Feinstein
Journal:  Curr Cardiol Rep       Date:  2010-11       Impact factor: 2.931

6.  Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts.

Authors:  D S Cross; C A McCarty; E Hytopoulos; M Beggs; N Nolan; D S Harrington; T Hastie; R Tibshirani; R P Tracy; B M Psaty; R McClelland; P S Tsao; T Quertermous
Journal:  Curr Med Res Opin       Date:  2012-11       Impact factor: 2.580

7.  Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.

Authors:  Michel M Joosten; Jennifer K Pai; Monica L Bertoia; Eric B Rimm; Donna Spiegelman; Murray A Mittleman; Kenneth J Mukamal
Journal:  JAMA       Date:  2012-10-24       Impact factor: 56.272

8.  Cardiovascular risk factors and clinical presentation in acute coronary syndromes.

Authors:  A Rosengren; L Wallentin; M Simoons; A K Gitt; S Behar; A Battler; D Hasdai
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

9.  Evaluating incremental values from new predictors with net reclassification improvement in survival analysis.

Authors:  Yingye Zheng; Layla Parast; Tianxi Cai; Marshall Brown
Journal:  Lifetime Data Anal       Date:  2012-12-20       Impact factor: 1.588

Review 10.  Socioeconomic status and cardiovascular disease: risks and implications for care.

Authors:  Alexander M Clark; Marie DesMeules; Wei Luo; Amanda S Duncan; Andy Wielgosz
Journal:  Nat Rev Cardiol       Date:  2009-09-22       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.